NCT04971031View on ClinicalTrials.gov

A Clinical Trial to Assess Subjects With Dry Eye Disease.

PHASE2CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

June 15, 2021

Primary Completion Date

September 8, 2021

Study Completion Date

September 8, 2021

Conditions
Dry Eye
Interventions
DRUG

Reproxalap Ophthalmic Solution (0.25%)

Reproxalap Ophthalmic Solution (0.25%) administered 7 times over two consecutive days.

DRUG

Vehicle Ophthalmic Solution

Vehicle Ophthalmic Solution administered 7 times over two consecutive days.

Trial Locations (1)

01810

Andover Eye Associates, Andover

Sponsors
All Listed Sponsors
lead

Aldeyra Therapeutics, Inc.

INDUSTRY